The rate of tobacco use among American adults with major depression, substance use disorder or both was found to have decreased between 2006 and 2019, according to the results of a study published on ...

Please provide your email address to receive an email when new articles are posted on . Physicians are busy and do not have much time for ongoing medical education. Trainees and attending physicians ...

Among patients with type 2 diabetes and tobacco use disorder (TUD), use of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy) was associated with a reduced risk of medical encounters for TUD ...

PARIS — "We need to develop new therapies to treat addiction because of the related cost to society, which is extremely high," said Bruno Roméo, MD, psychiatrist and addiction specialist at the Paul ...

A University of York professor has called for urgent international action to tackle what he describes as an "unseen epidemic" ...

Please provide your email address to receive an email when new articles are posted on . Among co-users, 26.5% and 28.3% reported anxiety and depression, respectively. Coordination of tobacco and ...

Lower risk for medical encounters for tobacco use disorder diagnosis seen in association with semaglutide vs other antidiabetes meds. HealthDay News — For patients with type 2 diabetes mellitus (T2DM) ...

Ozempic may be able to help people quit smoking and potentially reduce the need for additional anti-smoking aids, a new study claims. Researchers from Case Western Reserve School of Medicine examined ...

Nicotine & Tobacco Research, Vol. 20, No. 1 (January 2018), pp. 12-21 (10 pages) Oral Potentially Malignant Disorders (OPMDs) are chronic lesions or conditions characterized by a potential for ...